The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 160, 92-99
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and XposeCPT: Pharmacometrics & Systems Pharmacology, 2013
- Outcome and toxicity of radiotherapy combined with chemotherapy or cetuximab for head and neck cancer: Our experience in one hundred and twenty‐five patientsClinical Otolaryngology, 2013
- Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatinAnalytical and Bioanalytical Chemistry, 2008
- Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrateJournal of Mass Spectrometry, 2006
- Density and hydration of fresh and fixed human skeletal muscleJournal of Biomechanics, 2005
- Quantification of Lean BodyweightClinical Pharmacokinetics, 2005
- Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional imageJournal of Applied Physiology, 2004
- Population pharmacokinetics of total and unbound plasma cisplatin in adult patientsBritish Journal of Clinical Pharmacology, 2004
- Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adductsCancer Chemotherapy and Pharmacology, 1995
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976